Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B

BACKGROUND: The risk of hepatitis B reactivation in hepatitis B surface antigen-negative phase of hepatitis B virus-infected patients exposed to biologic agents is not clear. We aimed to investigate the reactivation rate in hepatitis B surface antigen-negative phase of hepatitis B virus-infected pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ergenç, İlkay, Kani, Haluk Tarık, Karabacak, Murat, Cömert Özer, Elif, Mehdiyev, Shahin, Jafarov, Fuad, Abacar, Kerem Yiğit, Kutluğ Ağaçkıran, Seda, Sevik, Gizem, Aslan, Rahmi, Alibaz Öner, Fatma, İnanç, Nevsun, Atagündüz, Mehmet Pamir, Seçkin, Dilek, Özen Alahdab, Yeşim, Ergun, Tülin, Direskeneli, Haner, Atuğ, Özlen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081030/
https://www.ncbi.nlm.nih.gov/pubmed/36445058
http://dx.doi.org/10.5152/tjg.2022.22196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081030/
https://www.ncbi.nlm.nih.gov/pubmed/36445058
http://dx.doi.org/10.5152/tjg.2022.22196

Ejemplares similares